Glioblastom clinical trials

Explore recruiting glioblastom clinical trials.

Also recruiting in Europe

Glioblastom trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A study to evaluate the safety and efficacy of the tumor-targeting human antibody-cytokine fusion protein L19TNF plus standard temozolomide chemoradiotherapy in patients with newly diagnosed glioblastoma.

Germany, Italy

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Itraconazole (ITRA) with standard radiotherapy (RT) and temozolomide (TMZ) in patients with newly diagnosed glioblastoma multiforme (GBM) ITRA-RAD: Phase I Clinical Study

Germany

Human Pharmacology (Phase I)- Other EU CTIS Study details

Phase II trial of vaccination with lysate-loaded, mature dendritic cells integrated into standard radiochemotherapy in newly diagnosed glioblastoma

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

EORTC 2227-BTG: Lomustine with or without reirradiation for first progression of glioblastoma: a randomized phase III study (LEGATO)

Italy, France, Norway, Spain, Belgium, Austria +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Early-stage clinical trial investigating the individual and combined effect of two drugs, senicapoc and perampanel, as part of the treatment for newly diagnosed glioblastoma, which is an aggressive brain tumor

Denmark

Human Pharmacology (Phase I)- Other EU CTIS Study details

Clinical and translational controlled study of Perampanel treatment around Surgery in patients with progressive glioblastoma (PerSurge)

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Glioblastom trials by city

Glioblastom in Toronto Glioblastom in Vancouver Glioblastom in Montreal Glioblastom in Calgary Glioblastom in Edmonton Glioblastom in Ottawa Glioblastom in Winnipeg Glioblastom in Quebec City Glioblastom in Hamilton Glioblastom in Kitchener Glioblastom in London Glioblastom in Halifax Glioblastom in New York Glioblastom in Los Angeles Glioblastom in Chicago Glioblastom in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease